Individualizing prophylaxis in hemophilia: a review.

Individualizing prophylaxis in hemophilia: a review.

Item
http://www.wikidata.org/entity/Q38323857
Profile of efraloctocog alfa and its potential in the treatment of hemophilia A.Baby hamster kidney cell-derived recombinant factor VIII: a quarter century of learning and clinical experience.The second Team Haemophilia Education Meeting, 2016, Frankfurt, Germany.Safety and efficacy of BAY 94-9027, a prolonged-half-life factor VIII.Experience of tailoring prophylaxis using factor VIII pharmacokinetic parameters estimated with myPKFiT® in patients with severe haemophilia A without inhibitors.Patient powered prophylaxis: A 12-month study of individualized prophylaxis in adults with severe haemophilia A.Break-through bleeding in relation to pharmacokinetics of Factor VIII in paediatric patients with severe haemophilia A.An innovative outcome-based care and procurement model of hemophilia management.Educational needs of hematologists and laboratory professionals regarding factor activity assays.
P2860

Individualizing prophylaxis in hemophilia: a review.

Item
http://www.wikidata.org/entity/Q38323857
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Individualizing prophylaxis in hemophilia: a review.
@en
type
label
Individualizing prophylaxis in hemophilia: a review.
@en
prefLabel
Individualizing prophylaxis in hemophilia: a review.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P577
P698
P921
P356
P1433
P1476
Individualizing prophylaxis in hemophilia: a review.
@en
P2093
P2860
P304
P31
P356
10.1586/17474086.2015.1002465
P433
P478
P577
P698
P921